Water Loss and Atopic Dermatitis Request More Information Trial Objective Researchers are studying how much water is lost from the skin of patients with Atopic Dermatitis (eczema) before and after using the medication Dupilumab. Patients’ skin will be tested through a noninvasive process called skin taping to study protein levels in the skin. Enrollment Active Clinical Trials Currently Recruiting Who Can Participate Adolescents 12-17, Adults 18-65-years-old Age: 12-65 Gender: Any Gender Estimated Time Commitment 13 visits over 24 weeks × Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit. Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study. Payment & Reimbursement Payment: Provided Travel Reimbursement: Not Available Trial Contact For more information, contact: Marco Ramirez-Gama 303.398.1409 Request More Information Trial Location National Jewish Main Campus, Denver, CO Trial Sponsors Sanofi-Aventis Principal Investigators Donald Leung, PhD, MD + × Donald Leung, PhD, MD Professor Head, Division of Pediatric Allergy & Immunology Department of Pediatrics View Full Profile Make an Appoinment Co-Investigators Anna Meyer, MD, PhD + × Anna Meyer, MD, PhD Assistant Professor Division of Pediatric Allergy & Clinical Immunology Department of Pediatrics View Full Profile Make an Appoinment Mark Boguniewicz, MD + × Mark Boguniewicz, MD Professor Division of Pediatric Allergy & Clinical Immunology Department of Pediatrics View Full Profile Patient Rating 4.6 out of 5 stars Make an Appoinment Request More Information Complete this form to learn more about this study and see if you qualify. First Name:* Last Name:* Email Address:* Phone:*
Trial Objective Researchers are studying how much water is lost from the skin of patients with Atopic Dermatitis (eczema) before and after using the medication Dupilumab. Patients’ skin will be tested through a noninvasive process called skin taping to study protein levels in the skin.